Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-31.3%-8.7pp-30.7%-11.6pp-29.8%-12.1pp-26.8%-8.7pp-22.6%-2.4pp
Return on assets-29.8%-8.0pp-29.2%-10.9pp-28.5%-11.5pp-25.8%-8.4pp-21.8%-2.3pp
Return on invested capital-37.1%-7.3pp-37.9%-12.0pp-38%-12.9pp-36.2%-10.4pp-29.8%-3.0pp
Efficiency
Asset turnover
Liquidity
Current ratio22.3×-6.1×17.1×-12.2×18.7×-15.9×25.1×-16.3×28.4×-10.2×
Quick ratio22.3×-6.1×17.1×-12.2×18.7×-15.9×25.1×-16.3×28.4×-10.2×
Cash ratio1.3×-0.4×1.3×-1.4×1.4×-2.7×2.3×-4.9×1.7×-2.5×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$3.55-11.6%$3.71-13.4%$3.51-21.3%$3.75-18.9%$4.02-15.8%
Valuation
Market capitalization$860.66M+305%$534.32M+52.9%$428.82M+40.9%$225.37M+19.1%$219.1M-2.9%
Enterprise value$850.62M+324%$519M+57.7%$415.47M+50.3%$207.61M+42.0%$207.58M+4.3%
Price / book3.9×+3.0×2.5×+1.1×2.1×+0.9×1.1×+0.3×+0.1×
Free cash flow yield-6.3%+16.2pp-10.2%+2.2pp-12.2%+3.0pp-22.5%+4.7pp-21.8%+2.2pp
Earnings yield-8.1%+18.4pp-13.1%+1.1pp-15.7%0.0pp-28.2%-1.5pp-25.6%+0.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Design Therapeutics, Inc.'s ratios come from?
Every ratio is computed from Design Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.